Provide a valuable resource to your clients or customers by linking to this resource page. Just place the following link on your website.
Bioavailability is the amount of a drug dose that reaches the bloodstream in an active form. It helps explain how much medicine is available to act in the body. Intravenous medicines have full bioavailability because they go directly into the bloodstream. Oral medicines can have lower bioavailability because absorption and first-pass metabolism can reduce the amount that reaches circulation.
read more about bioavailability ...After a medicine is taken, it must reach systemic circulation before it can act throughout the body. The route of administration, formulation, dissolution, absorption, and metabolism can all affect bioavailability. A tablet, capsule, liquid, injection, patch, or inhaled product can deliver different amounts of active medicine. Food and digestive conditions can also change absorption for some drugs.
Bioavailability helps explain why the same dose by two routes can produce different effects. A drug taken by mouth might need a different dose than the same drug given by injection. It can also guide generic comparison, formulation design, and dosing changes. Low or variable bioavailability can make treatment less predictable.
Factors that affect bioavailability include drug solubility, stomach emptying, intestinal absorption, liver metabolism, gut metabolism, food, and drug formulation. First-pass metabolism can reduce the amount of oral medicine before it reaches the bloodstream. Controlled-release products can change the rate of absorption. Crushing certain extended-release products can be dangerous because it can change drug release.
Absorption describes how a drug moves from the administration site into the body. Bioavailability describes how much active drug reaches systemic circulation. A drug can be absorbed but still have reduced bioavailability if it is heavily metabolized before reaching the bloodstream. This distinction helps explain why route and formulation can change drug response.
No, bioavailability and absorption are related but not identical. Absorption is movement into the body, while bioavailability is the amount of active drug that reaches systemic circulation.
IV bioavailability is 100% because the medicine enters the bloodstream directly. It does not need to pass through the digestive tract first.
Yes, food can increase, decrease, or delay bioavailability for certain medicines. Some labels direct patients to take a drug with food or on an empty stomach for this reason.
Yes, tablets, liquids, injections, patches, and extended-release forms can have different bioavailability. Prescribers account for this when changing a medicine form or route.
Drug Bioavailability. StatPearls (NCBI Bookshelf). https://www.ncbi.nlm.nih.gov/books/NBK557852/. Date Accessed June 3, 2026.
Drug Bioavailability. MSD Manual Professional Edition. https://www.msdmanuals.com/professional/clinical-pharmacology/pharmacokinetics/drug-bioavailability. Date Accessed June 3, 2026.
Drug Absorption. StatPearls (NCBI Bookshelf). https://www.ncbi.nlm.nih.gov/books/NBK557405/. Date Accessed June 3, 2026.
Pharmacokinetics. StatPearls (NCBI Bookshelf). https://www.ncbi.nlm.nih.gov/books/NBK557744/. Date Accessed June 3, 2026.
Bioavailability and Bioequivalence Studies Submitted in NDAs or INDs: General Considerations. U.S. Food & Drug Administration. https://www.fda.gov/files/drugs/published/Bioavailability-and-Bioequivalence-Studies-Submitted-in-NDAs-or-INDs-%E2%80%94-General-Considerations.pdf. Date Accessed June 3, 2026.